Although a number of studies on GREM-1 have examined its function in the control of patterning during embryonic development and regulation of early limb, lung, kidney and bone development, increased GREM-1 expression has also been described in various cancers including lung, kidney, ovary, breast, colon and pancreatic cancers [83–86]. Here, GREM1 is linked to pancreatic neoplasm.